Starr Ephraim
Transaction: 07/31/2026
BUY
Change
+335
Price
$24.17
Filing
08/04/2026
Type
BUY
Azenta, Inc.
AZTA • Medical - Instruments & Supplies
$31.33
▲ +0.15 (+0.48%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.42B
Growth
3.0%
Cash Flow
3/5
Trend
Mostly stable
Evidence
Positive revenue growth · 17.0%Positive free cash flow · 0.84Manageable debt level · 0.06Healthy liquidity · 2.98Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:07 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$31.33
Change0.48%
Shares Out45.29M
Market Cap$1.42B
Enterprise Value$1.09B
52W Range15.93 - 41.73
Beta1.37
P/E-11.54
P/S2.31
P/B0.94
P/FCF143.59
EV/Sales1.78
Price$31.33
Change0.48%
Shares Out45.29M
Market Cap$1.42B
Enterprise Value$1.09B
52W Range15.93 - 41.73
Beta1.37
P/E-11.54
P/S2.31
P/B0.94
P/FCF143.59
EV/Sales1.78
EV/EBITDA37.07
EV/FCF110.62
Earnings Yield-8.66%
FCF Yield0.70%
Dividend Yield0.00%
Gross Margin45.52%
Oper. Margin-1.90%
Profit Margin-9.39%
Debt/Eq0.06
Current Ratio2.98
Quick Ratio2.66
Revenue 5Y3.05%
Target$43.00
Target Upside37.25%
Target Median$44.50
Target Range38.00 - 45.00
Volume722.74K
Avg Volume1.03M
EPS Surprise-0.14
Investment DNA
How strong this company looks for long-term investors
52
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
58/100
Price Attractiveness
Cheap or expensive today
67/100
Why this score▼
Positive revenue growth · 17.0%Positive free cash flow · 0.84Manageable debt level · 0.06Healthy liquidity · 2.98Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 12 analyst votes · 2026-09-04
79/100
Bullish
Bullish
7
Hold
5
Bearish
0
Price Target
2026-08-07
Low
$38.00
Mean
$43.00
Median
$44.50
High
$45.00
Insider Transactions
Recent executive and insider activity
Cornog William L
Transaction: 05/18/2026
BUY
Change
+10,000
Price
$16.38
Filing
05/19/2026
Type
BUY
Starr Ephraim
Transaction: 05/15/2026
SELL
Change
-3,621
Price
$16.02
Filing
05/18/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Starr Ephraim | BUY | +335 | $24.17 | 07/31/2026 | 08/04/2026 |
| Cornog William L | BUY | +10,000 | $16.38 | 05/18/2026 | 05/19/2026 |
| Starr Ephraim | SELL | -3,621 | $16.02 | 05/15/2026 | 05/18/2026 |
| Koffey Quentin | BUY | +5,663 | Not reported | 02/05/2026 | 05/12/2026 |
| MARTIN WILLIAM E. III | BUY | +17,790 | $24.24 | 04/28/2026 | 04/30/2026 |
| MARTIN WILLIAM E. III | OTHER | 0 | Not reported | 04/06/2026 | 04/16/2026 |
| Nova Tina Susan | BUY | +5,663 | $27.85 | 02/06/2026 | 02/06/2026 |
| Davis Robyn C | BUY | +5,663 | Not reported | 02/05/2026 | 02/06/2026 |
| McLaughlin Erica | BUY | +5,663 | $27.85 | 02/05/2026 | 02/06/2026 |
| Casal Frank | BUY | +7,243 | $27.85 | 02/05/2026 | 02/06/2026 |
| Doshi Dipal | BUY | +5,663 | $27.85 | 02/05/2026 | 02/06/2026 |
| Madaus Martin D | BUY | +5,663 | Not reported | 02/05/2026 | 02/06/2026 |
| Cornog William L | BUY | +5,663 | Not reported | 02/05/2026 | 02/06/2026 |
| Cornog William L | OTHER | 0 | Not reported | 02/05/2026 | 02/06/2026 |
| Marotta John | BUY | +118,194 | Not reported | 11/24/2025 | 12/03/2025 |
| Starr Ephraim | BUY | +34,235 | Not reported | 11/24/2025 | 11/25/2025 |
| Zhou Ginger | BUY | +13,042 | Not reported | 11/24/2025 | 11/25/2025 |
| Pirogova Olga | BUY | +16,303 | Not reported | 11/24/2025 | 11/25/2025 |
| Lin Lawrence Y. | BUY | +36,681 | Not reported | 11/24/2025 | 11/25/2025 |
| Marotta John | BUY | +122,269 | Not reported | 11/24/2025 | 11/25/2025 |